Clinical Trial: A 28-Week Open Label Extension Study Evaluating Safety and Tolerability of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A 28-Week Open Label Extension Study Evaluating Safety and Tolerability of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment
Brief Summary: This is a multi-center, open-label study of 28 weeks duration in subjects with Mild Cognitive Impairment who have completed the double-blind study (E2020-A001-412).
Detailed Summary:
Sponsor: Eisai Inc.
Current Primary Outcome: Number of Participants With Treatment-Emergent Adverse Events [ Time Frame: Baseline, Week 6, Week 12 and Week 28. ]
Original Primary Outcome: Safety [ Time Frame: Baseline, Week 6, Week 12 and Week 28. ]
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Eisai Inc.
Dates:
Date Received: May 14, 2009
Date Started: February 2006
Date Completion:
Last Updated: December 12, 2013
Last Verified: December 2013